The Brazil Veterinary Medicine Market was valued at USD 2.65 Billion in 2024, and is projected to reach USD 4.15 Billion by 2030, rising at a CAGR of 7.90%. The rising pet ownership rate, increased livestock production, and growing demand for advanced veterinary pharmaceuticals and vaccines drive market growth. Expanding government initiatives to improve animal health and the increasing presence of veterinary medicine providers further contribute to market expansion. Advancements in veterinary drug formulations and efforts to enhance disease prevention strategies are also supporting market growth. The growing emphasis on animal welfare and improved access to veterinary healthcare solutions is expected to drive further adoption of veterinary medicines across Brazil.
Brazil is one of the world’s largest exporters of beef and poultry, and this status encourages farmers to adopt rigorous health management practices, including regular veterinary care, vaccination, and disease prevention measures, to ensure high-quality animal protein output. According to the OECD, in 2023, Brazil's beef and veal meat consumption was projected to reach 18.1 kg per person, as compared to 17.8 kg per person in 2022. As demand for meat rises, livestock production scales up, requiring improved animal health practices to ensure meat quality and safety standards. Moreover, producers are motivated to invest in animal health to ensure that livestock remains free from diseases and meets the standards for both local consumption and export. This focus on preventive and therapeutic veterinary care further stimulates market growth as producers seek solutions to maintain animal welfare, improve feed efficiency, and reduce mortality rates.
Furthermore, the growth of veterinary healthcare facilities, including new animal clinics and specialized care centers, strengthens the Brazil Veterinary Medicine Market. Better access to veterinary services and improved diagnostic tools are helping detect diseases early and provide effective treatments. In addition, a stronger focus on sustainable livestock management and responsible use of antibiotics is driving the adoption of eco-friendly veterinary solutions. These trends are shaping the market and supporting its continued growth.
This product will be delivered within 1-3 business days.
Brazil is one of the world’s largest exporters of beef and poultry, and this status encourages farmers to adopt rigorous health management practices, including regular veterinary care, vaccination, and disease prevention measures, to ensure high-quality animal protein output. According to the OECD, in 2023, Brazil's beef and veal meat consumption was projected to reach 18.1 kg per person, as compared to 17.8 kg per person in 2022. As demand for meat rises, livestock production scales up, requiring improved animal health practices to ensure meat quality and safety standards. Moreover, producers are motivated to invest in animal health to ensure that livestock remains free from diseases and meets the standards for both local consumption and export. This focus on preventive and therapeutic veterinary care further stimulates market growth as producers seek solutions to maintain animal welfare, improve feed efficiency, and reduce mortality rates.
Furthermore, the growth of veterinary healthcare facilities, including new animal clinics and specialized care centers, strengthens the Brazil Veterinary Medicine Market. Better access to veterinary services and improved diagnostic tools are helping detect diseases early and provide effective treatments. In addition, a stronger focus on sustainable livestock management and responsible use of antibiotics is driving the adoption of eco-friendly veterinary solutions. These trends are shaping the market and supporting its continued growth.
Brazil Veterinary Medicine Market Report Highlights
- By product, pharmaceuticals dominated the market with a share of 67.58% in 2024. However, the biologics segment is expected to grow at the highest CAGR of 8.8% during the forecast period. This growth is driven by increasing demand for vaccines and immunotherapies, along with advancements in biotechnology improving disease prevention and treatment in animals.
- By animal type, production animals held the largest market share in 2024, driven by the growing demand for livestock healthcare and disease management solutions. However, the companion animals segment is expected to grow at the fastest CAGR during the forecast period. This growth is supported by the rising pet population, increasing pet healthcare awareness, and a greater focus on preventive treatments for household animals.
- By route of administration, the injectable segment held the largest market share in 2024 due to its effectiveness in delivering fast-acting treatments for both companion and production animals. However, the other routes segment, including intranasal delivery, controlled-release implants, and transdermal patches, is expected to grow the most during the forecast period. This growth is driven by the increasing adoption of alternative drug delivery methods that enhance convenience, reduce animal stress, and improve treatment adherence.
- By distribution channel, veterinary hospitals and clinics held the largest market share in 2024. The e-commerce segment is expected to grow at the highest CAGR, driven by the convenience and accessibility of online veterinary products.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Brazil Veterinary Medicine Market Variables, Trends, & Scope
Chapter 4. Brazil Veterinary Medicine Market: Animal Estimates & Trend Analysis
Chapter 5. Brazil Veterinary Medicine Market: Product Estimates & Trend Analysis
Chapter 6. Brazil Veterinary Medicine Market: Type of Vaccine Estimates & Trend Analysis
Chapter 7. Brazil Veterinary Medicine Market: Disease Estimates & Trend Analysis
Chapter 8. Brazil Veterinary Medicine Market: Route of Administration Estimates & Trend Analysis
Chapter 9. Brazil Veterinary Medicine Market: Distribution Channel Estimates & Trend Analysis
Chapter 10. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this Brazil Veterinary Medicine market report include:- Zoetis Services LLC
- Ceva
- Merck & Co., Inc.
- Vetoquinol
- Boehringer Ingelheim International GmbH.
- Elanco
- Virbac
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals limited (Dechra Topco Limited)
- Bimeda, Inc.
- Biogénesis Bagó
- Ourofino Saúde Animal
- FARMABASE
- Vetnil
- Alivira Animal Health Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 2.65 Billion |
| Forecasted Market Value ( USD | $ 4.15 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Brazil |
| No. of Companies Mentioned | 16 |
